Singulair, originally sold by Merck & Co., is a prescription drug that was launched in 1998 and is used to prevent and treat symptoms of asthma and allergies, according to the Cleveland Clinic ...

Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, ...

The drug Singulair is typically prescribed to patients with allergies or asthma. The medication has received attention recently due to its being linked to mental health side effects including ...

Australia’s Therapeutic Goods Administration (TGA) has called for more prominent safety warnings about the neuropsychiatric ...

placebo-controlled trial to test the drug montelukast (Singulair) in patients at risk for post-traumatic osteoarthritis (OA). The project is titled “Montelukast as a potential chondroprotective ...